Newly discovered gene fusion may lead to improved prostate cancer diagnosis

Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers. The results may lead to more accurate prostate cancer testing and new targets for potential treatments. Experts believe that gene fusions -- a hybrid gene formed from two previously separated genes -- may be at the root of what causes cancer cells to grow more quickly than normal cells.

Read the whole article on Physorg

More from Physorg